Cargando…

Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization

We describe the technological development of a web platform named CHRONIC-PHARMA that integrates three prescription support tools for patients with chronic diseases: Anticholinergic Burden Calculator (ABC), LESS-CHRON criteria and TRIGGER-CHRON. They focus on the optimization and evaluation of pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalba-Moreno, Angela María, Galván-Banqueri, Mercedes, Rodríguez-Pérez, Aitana, Toscano-Guzmán, María Dolores, López-Hermoso, Clara, Sánchez-Fidalgo, Susana, Santos-Ramos, Bernardo, Alfaro-Lara, Eva Rocío
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885479/
https://www.ncbi.nlm.nih.gov/pubmed/35226192
http://dx.doi.org/10.1007/s10916-022-01808-0
_version_ 1784660429936525312
author Villalba-Moreno, Angela María
Galván-Banqueri, Mercedes
Rodríguez-Pérez, Aitana
Toscano-Guzmán, María Dolores
López-Hermoso, Clara
Sánchez-Fidalgo, Susana
Santos-Ramos, Bernardo
Alfaro-Lara, Eva Rocío
author_facet Villalba-Moreno, Angela María
Galván-Banqueri, Mercedes
Rodríguez-Pérez, Aitana
Toscano-Guzmán, María Dolores
López-Hermoso, Clara
Sánchez-Fidalgo, Susana
Santos-Ramos, Bernardo
Alfaro-Lara, Eva Rocío
author_sort Villalba-Moreno, Angela María
collection PubMed
description We describe the technological development of a web platform named CHRONIC-PHARMA that integrates three prescription support tools for patients with chronic diseases: Anticholinergic Burden Calculator (ABC), LESS-CHRON criteria and TRIGGER-CHRON. They focus on the optimization and evaluation of pharmacotherapy in patients with chronic diseases, resulting in a useful, single platform that can facilitate the review of pharmacotherapy and improve the safety of chronically ill patients. This is achieved by estimating and reducing the anticholinergic risk (ABC), detecting opportunities for deprescribing drugs and monitoring its success (LESS-CHRON criteria), as well as calculating the risk of adverse drug events (TRIGGER-CHRON). The platform is freely accessible online (https://chronic-pharma.com/) as well as through a mobile application, and therefore easily accessible among the healthcare community.
format Online
Article
Text
id pubmed-8885479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-88854792022-03-02 Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization Villalba-Moreno, Angela María Galván-Banqueri, Mercedes Rodríguez-Pérez, Aitana Toscano-Guzmán, María Dolores López-Hermoso, Clara Sánchez-Fidalgo, Susana Santos-Ramos, Bernardo Alfaro-Lara, Eva Rocío J Med Syst Implementation Science & Operations Management We describe the technological development of a web platform named CHRONIC-PHARMA that integrates three prescription support tools for patients with chronic diseases: Anticholinergic Burden Calculator (ABC), LESS-CHRON criteria and TRIGGER-CHRON. They focus on the optimization and evaluation of pharmacotherapy in patients with chronic diseases, resulting in a useful, single platform that can facilitate the review of pharmacotherapy and improve the safety of chronically ill patients. This is achieved by estimating and reducing the anticholinergic risk (ABC), detecting opportunities for deprescribing drugs and monitoring its success (LESS-CHRON criteria), as well as calculating the risk of adverse drug events (TRIGGER-CHRON). The platform is freely accessible online (https://chronic-pharma.com/) as well as through a mobile application, and therefore easily accessible among the healthcare community. Springer US 2022-02-28 2022 /pmc/articles/PMC8885479/ /pubmed/35226192 http://dx.doi.org/10.1007/s10916-022-01808-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Implementation Science & Operations Management
Villalba-Moreno, Angela María
Galván-Banqueri, Mercedes
Rodríguez-Pérez, Aitana
Toscano-Guzmán, María Dolores
López-Hermoso, Clara
Sánchez-Fidalgo, Susana
Santos-Ramos, Bernardo
Alfaro-Lara, Eva Rocío
Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title_full Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title_fullStr Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title_full_unstemmed Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title_short Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization
title_sort chronic-pharma: new platform for chronic patients pharmacotherapy optimization
topic Implementation Science & Operations Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885479/
https://www.ncbi.nlm.nih.gov/pubmed/35226192
http://dx.doi.org/10.1007/s10916-022-01808-0
work_keys_str_mv AT villalbamorenoangelamaria chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT galvanbanquerimercedes chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT rodriguezperezaitana chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT toscanoguzmanmariadolores chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT lopezhermosoclara chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT sanchezfidalgosusana chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT santosramosbernardo chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization
AT alfarolaraevarocio chronicpharmanewplatformforchronicpatientspharmacotherapyoptimization